Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISOTOVE intraperitoneal chemotherapy diffusion study
2012-004103-12Phase 2Active
- Sponsor
- Centre Jean Perrin
- Start
- Jun 2013
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of 5-fluorouracil + nab-paclitaxel + cisplatin + interleukin-2 in peritoneal carcinomatosis (PC) and ovarian cancer, sponsored by Centre Jean Perrin. Primary endpoint: Anatomical distribution and anomalies of isotope fixation. Started Jun 2013; status: active.
02
Drugs
5-fluorouracil + nab-paclitaxel + cisplatin + interleukin-2
03
Conditions
peritoneal carcinomatosis (PC)ovarian cancer
Beyond the preview
Go deeper on 2012-004103-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004103-12.